Clauser Noah 4
4 · Astria Therapeutics, Inc. · Filed Feb 12, 2024
Insider Transaction Report
Form 4
Clauser Noah
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-08+175,000→ 175,000 totalExercise: $15.26Exp: 2034-02-07→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 8, 2024 and is subject to vesting over a four-year period, with 25% of the 175,000 shares underlying the option upon grant vesting on the first anniversary of February 8, 2024 and the remainder vesting over the ensuing three years in equal monthly installments.